Back

15-month results of the MASTER DAPT trial.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: HOT LINE SESSION 8 Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

ESC TV

About the speaker

Photo
Professor Marco Valgimigli

Cardiocentro Ticino Institute, Lugano (Switzerland)

14 More presentations in this session

Presentation thumbnail
ISCHEMIA-CKD EXTEND - Clinical Outcomes at 5 years of Follow-up.
Professor S. Bangalore (New York, US)
Slides Video
Presentation thumbnail
Discussant review - ISCHEMIA-CKD EXTEND.
Professor D. Bhatt (New York City, US)
Slides Video
Presentation thumbnail
Panel discussion - ISCHEMIA-CKD EXTEND.
Video
Presentation thumbnail
Discussant review - MASTER DAPT.
Professor S. Schuepke (Munich, DE)
Slides Video
Presentation thumbnail
Panel discussion - MASTER DAPT.
Video

Access the full session

Session thumbnail
HOT LINE SESSION 8
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry
thumbnail
Congress Presentation
Ticagrelor or Clopidogrel to reduce ischemic events after Percutaneous Coronary Intervention in chronic coronary syndrome in clopidogrel naive patient: the ALPHEUS Naive sub-study.
thumbnail
Congress Session
Personalised dual antiplatelet therapy (DAPT) after acute coronary syndromes: difficult decisions

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources